Literature DB >> 28633308

Prior-Season Vaccination and Risk of Influenza During the 2014-2015 Season in the United States.

Jessie R Chung1, Brendan Flannery1, Richard K Zimmerman2, Mary Patricia Nowalk2, Michael L Jackson3, Lisa A Jackson3, Joshua G Petrie4, Emily T Martin4, Arnold S Monto4, Huong Q McLean5, Edward A Belongia5, Manjusha Gaglani6, Alicia M Fry1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28633308      PMCID： PMC5636178          DOI： 10.1093/infdis/jix286

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  10 in total

1.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

Authors:  Suzanne E Ohmit; Mark G Thompson; Joshua G Petrie; Swathi N Thaker; Michael L Jackson; Edward A Belongia; Richard K Zimmerman; Manjusha Gaglani; Lois Lamerato; Sarah M Spencer; Lisa Jackson; Jennifer K Meece; Mary Patricia Nowalk; Juhee Song; Marcus Zervos; Po-Yung Cheng; Charles R Rinaldo; Lydia Clipper; David K Shay; Pedro Piedra; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

2.  Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.

Authors:  Danuta M Skowronski; Catharine Chambers; Gaston De Serres; Suzana Sabaiduc; Anne-Luise Winter; James A Dickinson; Jonathan B Gubbay; Kevin Fonseca; Steven J Drews; Hugues Charest; Christine Martineau; Mel Krajden; Martin Petric; Nathalie Bastien; Yan Li; Derek J Smith
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

3.  Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.

Authors:  Marta Valenciano; Esther Kissling; Annicka Reuss; Caterina Rizzo; Alin Gherasim; Judit Krisztina Horváth; Lisa Domegan; Daniela Pitigoi; Ausenda Machado; Iwona Anna Paradowska-Stankiewicz; Antonino Bella; Amparo Larrauri; Annamária Ferenczi; Mihaela Lazar; Pedro Pechirra; Monika Roberta Korczyńska; Francisco Pozo; Alain Moren
Journal:  Euro Surveill       Date:  2016

4.  Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.

Authors:  Caterina Rizzo; Antonino Bella; Valeria Alfonsi; Simona Puzelli; Anna Pina Palmieri; Maria Chironna; Elena Pariani; Alessandra Piatti; Donatella Tiberti; Valeria Ghisetti; Roberto Rangoni; Maria Eugenia Colucci; Paola Affanni; Cinzia Germinario; Maria Rita Castrucci
Journal:  Vaccine       Date:  2016-05-04       Impact factor: 3.641

5.  Evaluation of self-reported and registry-based influenza vaccination status in a Wisconsin cohort.

Authors:  Stephanie A Irving; James G Donahue; David K Shay; Tina L Ellis-Coyle; Edward A Belongia
Journal:  Vaccine       Date:  2009-09-01       Impact factor: 3.641

6.  Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States.

Authors:  Manjusha Gaglani; Jessica Pruszynski; Kempapura Murthy; Lydia Clipper; Anne Robertson; Michael Reis; Jessie R Chung; Pedro A Piedra; Vasanthi Avadhanula; Mary Patricia Nowalk; Richard K Zimmerman; Michael L Jackson; Lisa A Jackson; Joshua G Petrie; Suzanne E Ohmit; Arnold S Monto; Huong Q McLean; Edward A Belongia; Alicia M Fry; Brendan Flannery
Journal:  J Infect Dis       Date:  2016-01-06       Impact factor: 7.759

7.  2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type.

Authors:  Richard K Zimmerman; Mary Patricia Nowalk; Jessie Chung; Michael L Jackson; Lisa A Jackson; Joshua G Petrie; Arnold S Monto; Huong Q McLean; Edward A Belongia; Manjusha Gaglani; Kempapura Murthy; Alicia M Fry; Brendan Flannery
Journal:  Clin Infect Dis       Date:  2016-10-04       Impact factor: 20.999

8.  Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type.

Authors:  Huong Q McLean; Mark G Thompson; Maria E Sundaram; Burney A Kieke; Manjusha Gaglani; Kempapura Murthy; Pedro A Piedra; Richard K Zimmerman; Mary Patricia Nowalk; Jonathan M Raviotta; Michael L Jackson; Lisa Jackson; Suzanne E Ohmit; Joshua G Petrie; Arnold S Monto; Jennifer K Meece; Swathi N Thaker; Jessie R Clippard; Sarah M Spencer; Alicia M Fry; Edward A Belongia
Journal:  J Infect Dis       Date:  2014-11-18       Impact factor: 5.226

9.  Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015.

Authors:  Brendan Flannery; Richard K Zimmerman; Larisa V Gubareva; Rebecca J Garten; Jessie R Chung; Mary Patricia Nowalk; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Suzanne E Ohmit; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Pedro A Piedra; Vasiliy P Mishin; Anton P Chesnokov; Sarah Spencer; Swathi N Thaker; John R Barnes; Angie Foust; Wendy Sessions; Xiyan Xu; Jacqueline Katz; Alicia M Fry
Journal:  J Infect Dis       Date:  2016-05-06       Impact factor: 7.759

10.  A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014-2015 Season.

Authors:  Danuta M Skowronski; Catharine Chambers; Suzana Sabaiduc; Gaston De Serres; Anne-Luise Winter; James A Dickinson; Mel Krajden; Jonathan B Gubbay; Steven J Drews; Christine Martineau; Alireza Eshaghi; Trijntje L Kwindt; Nathalie Bastien; Yan Li
Journal:  Clin Infect Dis       Date:  2016-03-29       Impact factor: 9.079
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.